Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel Cleansing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women aged from 18 to 75 years (included).~* Scheduled for a colonoscopy as an outpatient.~* Normal renal function~Exclusion Criteria:~* Having a disease or condition as follows:~  * repeated episodes of nausea and vomiting~ * abdominal pain due to severe infection or requiring surgery~ * clinically significant abnormal electrolytes values~ * congestive heart failure, unstable angina pectoris or recent myocardial infarction, percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass surgery within previous 3 months~ * known/suspected bowel obstruction, megacolon, ileus or intestinal perforation, or gastroparesis,~ * inflammatory bowel disease,~ * history of gastric stapling or bypass procedure or gastric retention~* Sodium phosphate preparation taken within the past three weeks prior to colonoscopy.~* Known allergy to any of the active ingredients or excipients of the study drugs.~* History of phenylketonuria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- polyethylene glycol (Type: ACTIVE_COMPARATOR): 4 Liters of PEG administered split in 2 doses
- oral sodium phosphate tablets (Type: EXPERIMENTAL): oral Sodium Phosphate tablets administered as 32 tablets (20+12) with 2 Liters of liquid

Based on this trial design, predict the completion outcome and termination type (if applicable).